

Please contact the doctor's office to verify that your insurance is accepted.
Dr. Gulick received his undergraduate degree from Johns Hopkins University in 1982. In his early career, he worked as a biologist in the Medicinal Chemistry Laboratory at the National Institutes of Health in Bethesda, MD. He went on to earn his MD degree at Columbia University College of Physicians and Surgeons in 1986 and his Master of Public Health degree at Harvard University in 1993, focusing on clinical trial design. After completing his internship and residency in internal medicine at Columbia-Presbyterian Medical Center in 1989, Dr. Gulick held fellowships in infectious diseases at Beth Israel Hospital and Massachusetts General Hospital in Boston from 1989-1991.
Dr. Gulick jo...
What we know about the cruise hantavirus outbreak and its origins
What Are Hantavirus Symptoms? Suspected Cruise Ship Outbreak Leaves 3 Dead
Should you really feed a cold and starve a fever?
Taken correctly, this mineral may shorten your cold
When should I get a flu shot?
A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
Antiretroviral Therapy.
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.